- This event has passed.
2nd Annual Pharmaceutical Biotechnology Congress
May 6 @ 8:00 am - May 7 @ 5:00 pmUSD699
Conferenceseries llc LTD proudly announces the commencement of “2nd Annual Pharmaceutical Biotechnology Congress” which is going to be held during May 06-07, 2019 at Tokyo, Japan.
Pharma Biotech Congress 2019 focuses upon “Comprehensive Innovations and Researches in Pharmaceutical Biotechnology”. This Pharma Biotech Conferences focuses on the trends which the biopharmaceutical market is heading on since its launch till the present date and moving on to the projections in future. It takes into its fold the critical developmental procedures, analyses, regulatory factors and also pharmacovigilance including post marketing surveillance and clinical studies. Innovation and compliance to regulatory guidelines are the most critical aspects towards biosimilars and follow on biologics development and successful launching to the market.
Why to attend???
Join your peers around the world focused on learning about Biopharmaceutics, Biologics and Biotechnology related advances, which is your single best opportunity to reach the largest assemblage of participants from the Biopharma community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates are hallmarks of this conference.
- Biopharma, Biotech, Pharma Industry CEO, Directors, R&D Researchers
- Business Entrepreneurs, Training Institutes, Software developing companies,
- Medical Devices Manufacturing Companies, CRO
- Data Management, Clinical Trial Conducting Organizations and Companies
- Students, Scientists, Researchers, and Faculty of Pharmaceutical Sciences
- Universities, Medical Colleges, Researchers from Pharmaceutical background
The Global Biopharmaceutical Market is poised to grow at a CAGR of around 10.1% over the next decade to reach approximately $459.81 billion by 2025.The opportunity in biopharmaceuticals is big and growing too rapidly to ignore. Today biopharmaceuticals generate global revenues of $163 billion, making up about 20%of the Pharma market. It’s by far the fastest-growing part of the industry. Biopharma’s current annual growth rate of more than 8% is double that of conventional Pharma, and growth is expected to continue at that rate for the foreseeable future.
It is estimated at USD 215 million for the year 2017 and is projected to reach USD 269 billion by the year 2021. The estimated CAGR during the forecast period (2017-2021) is 5.76%.
As the Japanese Pharma economy is in a state of transition towards greater openness, potential rewards for early international movers were cited as another key factor in the rapid shifts predicted in 2018.
The pharmaceutical market in Japan is set to rise from around $70 billion in 2016 to $72 billion by 2021, representing a low compound annual growth rate of 0.3%, according to Global Data, a recognized leader in providing business information and analytics.
Japan represents the world’s eighth biggest market for generic drugs in terms of value. Generic drugs, however, have traditionally enjoyed a relatively lower penetration in Japan compared to other developed markets such as the United States and Europe.
The Japanese government has identified growth of the country’s generic drug market as imperative to Japan’s long-term economic health
The penetration of generics has grown robustly over the past few years. The government has also made a target towards achieving a generic penetration of 60% by 2018. This is expected to create huge opportunities for both domestic and foreign generic manufacturers in Japan.
The biggest change for Pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Japanese officials proudly say some drug approvals in Japan are now faster than in both Europe and the U.S.—a marked change from the days when Japan was seen as a difficult market for foreign companies.
The topics of the Conference will truly reflect the current and future trends in on Pharmaceutical and Biotechnology The Congress will cover a cover a broad spectrum of Biopharmaceuticals, Novel Approaches in Biopharmaceutics, Nanoparticles in Biopharmaceuticals, Biotechnology in Health Care, Formulation of Biotech Products, Agriculture Biotechnology, Advances in Biotech Manufacturing, Biotechnology and its Applications, Biopharmaceutical Engineering, Chemical Biotechnology, Biomass& Bioenergy, Industrial and Microbial Biotechnology, Biopharmaceutical Production in Transgenic Animals, Development on Recombinant Protein, Drug Disposition & Pharmacokinetics, Pharmacodynamics, Biotech Companies and Market Analysis., Biopharmaceutical Pharmacovigilance, Bioavailability/Bioequivalence on Biopharmaceutical Products, Clinical Trials on Biopharmaceutical Products, Nanoparticles-An Innovative Drug Delivery System,
Conferenceseries Pharma Biotech Congress 2019 will offer you an unmatched attendee experience. In addition to the many scientific sessions and take-home case study examples, you will leave this event with many other novel development strategies from some of our workshops and symposiums. Engage in dynamic conversation with your industry peers at our multiple networking sessions, and takeaway novel drug development and commercialization strategies, which could speed up time to market and save your organization millions. We hope you will join us in Singapore this May.
We hope you will join us in Singapore, this May 06-07, 2019. Where your presence will be a key addition to enrich the meeting and set its standards high. To accomplish the same, submit you valuable research abstract to us for our Speaker Sessions and do register to the conference by following the link
Looking forward to see you at Tokyo, Japan.
Pharma Biotech Congress 2019
Conference Series llc Ltd
Phone: +1-702-508-5200 Ext: 8045
Customer Service: +1 (800) 216 6499